FGF21 and metabolic dysfunction-associated steatotic liver disease: They reported that hepatic FGF21 mRNA expression in NAFLD patients with grade 1 was 4-fold higher than that in grade 0 (p < 0.01), and grade 2–3 was 14.71-fold higher than that in grade 0 (p < 0.01).